Mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?

Cardiovascular intervention for myocardial revascularization dominates modern treatment of ischaemic heart disease (IHD). Current efficiency and safety of this method could never be achieved without the development of antiplatelet agents that provide indispensable protection for endovascular interve...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Irina Ziyatovna Bondarenko, Irina Alexandrovna Shirshina
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2013
Materias:	diabetes mellitus haemostasis ischaemic heart disease platelet functions Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/1ea0f7f3b1c54a869434ed4abbc4eb1e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1ea0f7f3b1c54a869434ed4abbc4eb1e
record_format	dspace
spelling	oai:doaj.org-article:1ea0f7f3b1c54a869434ed4abbc4eb1e2021-11-14T09:00:18ZMechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?2072-03512072-037810.14341/2072-0351-95https://doaj.org/article/1ea0f7f3b1c54a869434ed4abbc4eb1e2013-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/95https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Cardiovascular intervention for myocardial revascularization dominates modern treatment of ischaemic heart disease (IHD). Current efficiency and safety of this method could never be achieved without the development of antiplatelet agents that provide indispensable protection for endovascular interventions. However, antithrombotic therapy is generally less effective in diabetes mellitus (DM), affecting prognosis for transcutaneous intervention. This trend is probably due to alteration of cellular homeostasis during hyperglycemia and correlates with its severity and persistence. This paper addresses modern understanding of factors affecting thrombogenesis in patients with DM.Irina Ziyatovna BondarenkoIrina Alexandrovna ShirshinaEndocrinology Research Centrearticlediabetes mellitushaemostasisischaemic heart diseaseplatelet functionsNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 16, Iss 3, Pp 58-63 (2013)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus haemostasis ischaemic heart disease platelet functions Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus haemostasis ischaemic heart disease platelet functions Nutritional diseases. Deficiency diseases RC620-627 Irina Ziyatovna Bondarenko Irina Alexandrovna Shirshina Mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?
description	Cardiovascular intervention for myocardial revascularization dominates modern treatment of ischaemic heart disease (IHD). Current efficiency and safety of this method could never be achieved without the development of antiplatelet agents that provide indispensable protection for endovascular interventions. However, antithrombotic therapy is generally less effective in diabetes mellitus (DM), affecting prognosis for transcutaneous intervention. This trend is probably due to alteration of cellular homeostasis during hyperglycemia and correlates with its severity and persistence. This paper addresses modern understanding of factors affecting thrombogenesis in patients with DM.
format	article
author	Irina Ziyatovna Bondarenko Irina Alexandrovna Shirshina
author_facet	Irina Ziyatovna Bondarenko Irina Alexandrovna Shirshina
author_sort	Irina Ziyatovna Bondarenko
title	Mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?
title_short	Mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?
title_full	Mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?
title_fullStr	Mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?
title_full_unstemmed	Mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?
title_sort	mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?
publisher	Endocrinology Research Centre
publishDate	2013
url	https://doaj.org/article/1ea0f7f3b1c54a869434ed4abbc4eb1e
work_keys_str_mv	AT irinaziyatovnabondarenko mechanismsofthrombogenesisassociatedwithdiabetesmellituswhatdefinestheprognosisofinvasivemyocardialrevascularizationmethods AT irinaalexandrovnashirshina mechanismsofthrombogenesisassociatedwithdiabetesmellituswhatdefinestheprognosisofinvasivemyocardialrevascularizationmethods
_version_	1718429573741281280

Mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?

Ejemplares similares